ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 977,84
0,45%
Dow Jones
41 366,79
-0,16%
DAX
22 642,39
1,46%
Brent Oil
70,75
1,48%
Bitcoin
82 076,85
-0,93%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Silo Pharma Inc (SILO) Cours

Silo Pharma Inc

Silo Pharma Inc (SILO)

Silo Wellness Inc
1,2655
-0,0145
( -1,13% )
Mis à jour : 16:48:39
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
1,2655
Prix Achat
1,24
Prix Vente
1,27
Volume échangé
8 679
1,24 Fourchette du Jour 1,29
0,77 Plage de 52 semaines 4,50
Cap du marché
5,675M
Clôture Veille
1,28
Ouverture
1,25
Dernière Transaction
1
@
1.27
Dernière heure de transaction
16:54:12
Volume financier
US$ 10 990
VWAP
1,2663
Volume moyen (3 m)
3 457 899
Actions en circulation
4 484 456
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,54
Bénéfice par action (BPA)
-0,83
Chiffre d'affairess
72k
Bénéfice net
-3,7M

À propos de Silo Pharma Inc

Silo Pharma Inc. (Nasdaq: SILO) is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. Silo focuses on developing traditio... Silo Pharma Inc. (Nasdaq: SILO) is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. Silo focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The Company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. SP-26 is a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. Silo's two preclinical programs are SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). Silo's research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. Show more

Secteur
Apparel & Accessories, Nec
Industrie
Apparel & Accessories, Nec
Site Web
silopharma.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Silo Pharma Inc est coté dans le secteur Apparel & Accessories de la NASDAQ avec le ticker SILO. Le dernier cours de clôture d'Silo Pharma était de US$1,28. Au cours de la dernière année, les actions de Silo Pharma ont été négociées dans une fourchette de prix de US$ 0,77 à US$ 4,50.

Silo Pharma compte actuellement 4 484 456 actions en circulation. La capitalisation boursière d'Silo Pharma est de US$5,74 million. Silo Pharma a un ratio cours/bénéfice (ratio PE) de -1.54.

SILO Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report
Edgar (US Regulatory)
10 Mars 2025
SILO (-1,13%)

Form 8-K - Current report
Edgar (US Regulatory)
07 Mars 2025
SILO (-1,13%)

Form 8-K - Current report
Edgar (US Regulatory)
02 Janvier 2025
SILO (-1,13%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.02552.05645161291.241.341.21378461.2879758CS
4-0.2145-14.49324324321.481.5649031.2947971.39169555CS
120.385943.8722146430.87963.36990.834578991.70262194CS
260.195518.27102803741.073.36990.7716646431.64306025CS
52-0.3745-22.83536585371.644.50.7721958702.26567837CS
156-5.3345-80.82575757586.67.260.7710276732.33013703CS
260-5.3345-80.82575757586.67.260.7710276732.33013703CS

SILO - Frequently Asked Questions (FAQ)

What is the current Silo Pharma share price?
The current share price of Silo Pharma is US$ 1,2655
How many Silo Pharma shares are in issue?
Silo Pharma has 4 484 456 shares in issue
What is the market cap of Silo Pharma?
The market capitalisation of Silo Pharma is USD 5,74M
What is the 1 year trading range for Silo Pharma share price?
Silo Pharma has traded in the range of US$ 0,77 to US$ 4,50 during the past year
What is the PE ratio of Silo Pharma?
The price to earnings ratio of Silo Pharma is -1,54
What is the cash to sales ratio of Silo Pharma?
The cash to sales ratio of Silo Pharma is 78,88
What is the reporting currency for Silo Pharma?
Silo Pharma reports financial results in USD
What is the latest annual turnover for Silo Pharma?
The latest annual turnover of Silo Pharma is USD 72k
What is the latest annual profit for Silo Pharma?
The latest annual profit of Silo Pharma is USD -3,7M
What is the registered address of Silo Pharma?
The registered address for Silo Pharma is 501 SILVERSIDE ROAD, SUITE 102, WILMINGTON, DELAWARE, 19809
What is the Silo Pharma website address?
The website address for Silo Pharma is silopharma.com
Which industry sector does Silo Pharma operate in?
Silo Pharma operates in the APPAREL & ACCESSORIES, NEC sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
CRVOCervoMed Inc
US$ 5,2001
(120,34%)
89,75M
VSTEVast Renewable Ltd
US$ 0,7271
(45,45%)
168,15M
AREBAmerican Rebel Holdings Inc
US$ 0,43635
(43,58%)
89,51M
OPRXOptimizeRx Corporation
US$ 5,76
(39,13%)
14,02M
GRPNGroupon Inc
US$ 13,43
(37,46%)
5,91M
APDNApplied DNA Sciences Inc
US$ 0,0703
(-52,18%)
14,29M
ZYXIZynex Inc
US$ 3,555
(-49,21%)
1,25M
HITHealth In Tech Inc
US$ 4,36
(-41,55%)
1,53M
HEPAHepion Pharmaceuticals Inc
US$ 0,050136
(-40,31%)
42,48M
KBSXFST Corporation
US$ 2,50
(-37,50%)
54,92k
STISolidion Technology Inc
US$ 0,167
(32,43%)
483,94M
VSTEVast Renewable Ltd
US$ 0,7271
(45,45%)
168,15M
NVDANVIDIA Corporation
US$ 115,465
(6,16%)
164,92M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,095
(14,98%)
152,6M
CRVOCervoMed Inc
US$ 5,23
(121,61%)
89,77M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
SILO
Silo Pharma
TG
2SND
21Shares
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces